CDC and FDA Address Yellow Fever Vaccine Shortage — Physician’s First Watch

Medical News |
May 1, 2017

CDC and FDA Address Yellow Fever Vaccine Shortage

By the Editors

The FDA has authorized use of an international yellow fever vaccine (Stamaril) in the United States because supply of the only U.S.-licensed yellow fever vaccine (YF-VAX) is expected to be depleted by the middle of 2017, the CDC reports in MMWR.

The YF-VAX shortage resulted from manufacturing problems. Stamaril uses the same virus substrain as YF-VAX, and is similarly safe and efficacious.

The CDC recommends yellow fever vaccination for people aged 9 months and older who are traveling to or living in high-risk areas in South America and Africa.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.